By Kelly Mitchell, HealthyImmunityNow.org
You, me, and everyone we know. We can’t wait for any public health agency or government official.
Ivermectin is the drug that has been found to both prevent and treat COVID-19.
It’s cheap, readily available, covered by insurance, FDA licensed, with decades of safe use in hundreds of millions people annually.
Even with the rollout of investigational Emergency Use Authorized (EUA) COVID-19 vaccines, prevention options and effective treatments are needed. People are still becoming sick, seriously ill, and dying. Many are concerned about the safety and effectiveness of the vaccines, many are refusing to get them, as is their legal right under EUA requirements.
Ivermectin is a safe and effective prevention option and highly potent treatment.
Nations around the world are embracing it. The EU nation Slovakia has now authorized it as a prophylactic (preventative) and treatment. Macedonio, South Africa, Zimbabwe, Nicaragua, Belize, Columbia, Peru, the state of Chiapas in Mexico—wherever Ivermectin is used, they are seeing their rates of infection, hospitalization, and deaths plummet.
Ivermectin is a highly effective anti-parasite medication. People in the U.S. are most familiar with its use in veterinary medicine, but globally, it has saved millions of human lives, which earned it’s developers a Nobel Prize in 2015.
According to the Front Line COVID-19 Critical Care (FLCCC) alliance, which was founded by several of this nation’s top ICU doctors and pulmonary specialists, Ivermectin has been discovered to be a potent antiviral and anti-inflammatory. In a recent presentation, Dr. Kory of the FLCCC said that Ivermectin “significantly diminished viral load and protects against organ damage in animal models when infected with SARS-COV-2”, the virus that causes COVID-19.
He also presented clinical trial results in humans that showed Ivermectin:
- Prevents transmission and development of COVID-19 in those exposed to infected patients.
- Hastens recovery and prevents deterioration in patients with mild to moderate disease treated early after symptom onset
- Hastens recovery and avoidance of ICU admission and death in hospitalized patients
- Reduces mortality in critically ill patients with COVID-19
- Leads to striking reductions in case-fatality rates in regions with widespread use
Ivermectin is also showing promising results in treating the symptoms of “long-haulers.” You can find all the clinical trials, video interviews of recovered patients, video testimony of the FLCCC doctors testifying before Senate Committees and more at www.Covid19CriticalCare.com
This is a call to action. Nothing is more important. Go to the FLCCC website. Read deeply, then share with everyone you know. Tell your friends, your family, your neighbors, the UPS delivery person . . . everyone you see or talk to, in person, on the phone, online. Post it on every social media platform, send it to every one of your legislators, your doctors, your minister, your priest, your children’s schools, teachers, unions, business owners, CEO’s of major companies.
Together, we can end the pandemic and restore our lives and our liberty.